{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:51:25Z","timestamp":1794624685501,"version":"4.9.1"},"reference-count":161,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:p>Retinopathy of prematurity (ROP) is a significant cause of potentially preventable blindness in preterm infants worldwide. It is a disease caused by abnormal retinal vascularization that, if not detected and treated in a timely manner, can lead to retinal detachment and severe long term vision impairment. Neonatologists and pediatricians have an important role in the prevention, detection, and management of ROP. Geographic differences in the epidemiology of ROP have been seen globally over the last several decades because of regional differences in neonatal care. Our understanding of the pathophysiology, risk factors, prevention, screening, diagnosis, and treatment of ROP have also evolved over the years. New technological advances are now allowing for the incorporation of telemedicine and artificial intelligence in the management of ROP. In this comprehensive update, we provide a comprehensive review of pathophysiology, classification, diagnosis, global screening, and treatment of ROP. Key historical milestones as well as touching upon the very recent updates to the ROP classification system and technological advances in the field of artificial intelligence and ROP will also be discussed.<\/jats:p>","DOI":"10.1542\/peds.2021-053924","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T23:04:46Z","timestamp":1660172686000},"source":"Crossref","is-referenced-by-count":219,"title":["Retinopathy of Prematurity: A Global Perspective and Recent Developments"],"prefix":"10.1542","volume":"150","author":[{"given":"Kourosh","family":"Sabri","sequence":"first","affiliation":[{"name":"aDepartment of Ophthalmology, McMaster University, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L","family":"Ells","sequence":"additional","affiliation":[{"name":"bCalgary Retina Consultants, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"aDepartment of Ophthalmology, McMaster University, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Dutta","sequence":"additional","affiliation":[{"name":"cDepartment of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vinekar","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatric Retina, Narayana Nethralaya Eye Institute, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"key":"2023110816291126700_B1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"issue":"10","key":"2023110816291126700_B2","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"issue":"7","key":"2023110816291126700_B3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2023110816291126700_B4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02482615","article-title":"Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP)","volume":"74","author":"Palmer","year":"1990","journal-title":"Doc Ophthalmol"},{"key":"2023110816291126700_B5","first-page":"233","article-title":"Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"2023110816291126700_B6","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/bjo.2006.098582","article-title":"The early treatment for retinopathy of prematurity study: structural findings at age 2 years","volume":"90","author":"Good","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2023110816291126700_B7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.eye.6702939","article-title":"Anatomical and visual outcome of stages 4 and 5 retinopathy of prematurity","volume":"23","author":"Shah","year":"2009","journal-title":"Eye (Lond)"},{"issue":"3","key":"2023110816291126700_B8","first-page":"185","article-title":"Surgical management in advanced stages of retinopathy of prematurity; our experience","volume":"4","author":"Roohipoor","year":"2009","journal-title":"J Ophthalmic Vis Res"},{"issue":"5","key":"2023110816291126700_B9","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1167\/iovs.07-0632","article-title":"Vascular precursors in developing human retina","volume":"49","author":"Hasegawa","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2023110816291126700_B10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"issue":"12","key":"2023110816291126700_B11","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1002\/dvdy.20988","article-title":"The initial fetal human retinal vasculature develops by vasculogenesis","volume":"235","author":"McLeod","year":"2006","journal-title":"Dev Dyn"},{"issue":"7 Pt 1","key":"2023110816291126700_B12","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"issue":"9","key":"2023110816291126700_B13","first-page":"3429","article-title":"Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization","volume":"35","author":"Penn","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"2023110816291126700_B14","first-page":"3500","article-title":"Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion","volume":"43","author":"Dorrell","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2023110816291126700_B15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm.1873","article-title":"The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis","volume":"14","author":"Sapieha","year":"2008","journal-title":"Nat Med"},{"issue":"1","key":"2023110816291126700_B16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10633-009-9201-x","article-title":"Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy","volume":"120","author":"Kermorvant-Duchemin","year":"2010","journal-title":"Doc Ophthalmol"},{"issue":"50","key":"2023110816291126700_B17","doi-asserted-by":"crossref","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy","volume":"105","author":"Sears","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17","key":"2023110816291126700_B18","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.3390\/ijms20174321","article-title":"Vascular and neuronal protection in the developing retina: potential therapeutic targets for retinopathy of prematurity","volume":"20","author":"Tsang","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2023110816291126700_B19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of prematurity: a review of risk factors and their clinical significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"2023110816291126700_B20","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2004-1309","article-title":"Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network","volume":"115","author":"Darlow","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"2023110816291126700_B21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.2015.8841","article-title":"Association between intermittent hypoxemia or bradycardia and late death or disability in extremely preterm infants","volume":"314","author":"Poets","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"2023110816291126700_B22","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia. I. nursery observations","volume":"35","author":"Patz","year":"1952","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"2023110816291126700_B23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J Pediatr"},{"key":"2023110816291126700_B24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajo.2020.05.025","article-title":"Retinopathy of prematurity: evolving treatment with anti-vascular endothelial growth factor","volume":"218","author":"Hartnett","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2023110816291126700_B25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000322848","article-title":"A paradigm shift in the prevention of retinopathy of prematurity","volume":"100","author":"Raghuveer","year":"2011","journal-title":"Neonatology"},{"issue":"4","key":"2023110816291126700_B26","first-page":"CD011190","article-title":"Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants","volume":"4","author":"Askie","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2023110816291126700_B27","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1542\/neo.21-4-e249","article-title":"Strategies to prevent severe retinopathy of prematurity: a 2020 update and meta-analysis","volume":"21","author":"Raghuveer","year":"2020","journal-title":"Neoreviews"},{"issue":"21","key":"2023110816291126700_B28","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration","volume":"319","author":"Askie","year":"2018","journal-title":"JAMA"},{"key":"2023110816291126700_B29","unstructured":"NICE\n          . Quality statement 4: oxygen saturation. Available at: https:\/\/www.nice.org.uk\/consultations\/530\/6\/quality- statement-4-oxygen-saturation. Accessed April 8, 2022"},{"issue":"3","key":"2023110816291126700_B30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.clp.2019.05.015","article-title":"Current recommendations and practice of oxygen therapy in preterm infants","volume":"46","author":"Tarnow-Mordi","year":"2019","journal-title":"Clin Perinatol"},{"issue":"3","key":"2023110816291126700_B31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/pr.2016.98","article-title":"Graded oxygen saturation targets and retinopathy of prematurity in extremely preterm infants","volume":"80","author":"Cayabyab","year":"2016","journal-title":"Pediatr Res"},{"issue":"2","key":"2023110816291126700_B32","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1167\/iovs.16-20822","article-title":"Use of a supplemental oxygen protocol to suppress progression of retinopathy of prematurity","volume":"58","author":"Colaizy","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2023110816291126700_B33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaophthalmol.2018.7021","article-title":"Comparison of biphasic vs static oxygen saturation targets among infants with retinopathy of prematurity","volume":"137","author":"Shukla","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"2023110816291126700_B34","doi-asserted-by":"crossref","first-page":"j1039","DOI":"10.1136\/bmj.j1039","article-title":"Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study","volume":"356","author":"Travers","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"2023110816291126700_B35","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee opinion no. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","author":"Committee on Obstetric Practice","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2023110816291126700_B36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clp.2013.02.006","article-title":"Setting up and improving retinopathy of prematurity programs: interaction of neonatology, nursing, and ophthalmology","volume":"40","author":"Darlow","year":"2013","journal-title":"Clin Perinatol"},{"issue":"12","key":"2023110816291126700_B37","doi-asserted-by":"crossref","first-page":"e1003477","DOI":"10.1371\/journal.pmed.1003477","article-title":"Thresholds of glycemia, insulin therapy, and risk for severe retinopathy in premature infants: a cohort study","volume":"17","author":"Kermorvant-Duchemin","year":"2020","journal-title":"PLoS Med"},{"issue":"4","key":"2023110816291126700_B38","doi-asserted-by":"crossref","first-page":"e20153387","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"2023110816291126700_B39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"issue":"1","key":"2023110816291126700_B40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bjophthalmol-2017-310709","article-title":"A worldwide survey of retinopathy of prematurity screening","volume":"102","author":"Mora","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2023110816291126700_B41","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1136\/fetalneonatal-2011-301121","article-title":"Aggressive posterior retinopathy of prematurity in large preterm babies in South India","volume":"97","author":"Shah","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9","key":"2023110816291126700_B42","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/IAE.0b013e3181a68f3a","article-title":"Aggressive posterior retinopathy of prematurity in Asian Indian babies: spectrum of disease and outcome after laser treatment","volume":"29","author":"Sanghi","year":"2009","journal-title":"Retina"},{"issue":"4","key":"2023110816291126700_B43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajo.2010.10.007","article-title":"Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian twin cities ROP screening program report number 2","volume":"151","author":"Jalali","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2023110816291126700_B44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/09286586.2021.1910315","article-title":"Blindness secondary to retinopathy of prematurity in sub-Saharan Africa","author":"Herrod","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"2023110816291126700_B45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09286586.2019.1585885","article-title":"Retinopathy of prematurity in Africa: a systematic review","volume":"26","author":"Wang","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"2023110816291126700_B46","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2214-109X(18)30451-0","article-title":"Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis","volume":"7","author":"Chawanpaiboon","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"5","key":"2023110816291126700_B47","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/heapol\/czy004","article-title":"Reducing blindness from retinopathy of prematurity (ROP) in Argentina through collaboration, advocacy and policy implementation","volume":"33","author":"Hariharan","year":"2018","journal-title":"Health Policy Plan"},{"issue":"3","key":"2023110816291126700_B48","doi-asserted-by":"crossref","first-page":"151.e1","DOI":"10.1016\/j.jaapos.2020.03.002","article-title":"Current management of retinopathy of prematurity in sub-Saharan Africa","volume":"24","author":"Lloyd","year":"2020","journal-title":"J AAPOS"},{"issue":"6","key":"2023110816291126700_B49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.semperi.2019.05.004","article-title":"Primary prevention of ROP and the oxygen saturation targeting trials","volume":"43","author":"Darlow","year":"2019","journal-title":"Semin Perinatol"},{"key":"2023110816291126700_B50","unstructured":"Wilson\n              JMG\n            , JungnerG; World Health Organization. Principles and practice of screening for disease. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/37650 Accessed January 4, 2022"},{"issue":"6","key":"2023110816291126700_B51","doi-asserted-by":"crossref","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"2023110816291126700_B52","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0161-6420(01)01017-X","article-title":"A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. visual function and structural outcome","volume":"109","author":"Ng","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"2023110816291126700_B53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajo.2005.07.034","article-title":"Retinopathy of prematurity: the life of a lifetime disease","volume":"141","author":"Tasman","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2023110816291126700_B54","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.oret.2019.12.015","article-title":"Late-onset retinal findings and complications in untreated retinopathy of prematurity","volume":"4","author":"Hamad","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"2023110816291126700_B55","doi-asserted-by":"crossref","first-page":"100759","DOI":"10.1016\/j.preteyeres.2019.04.003","article-title":"Deep learning in ophthalmology: the technical and clinical considerations","volume":"72","author":"Ting","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"2023110816291126700_B56","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICU.0000000000000786","article-title":"Description and management of retinopathy of prematurity reactivation after intravitreal antivascular endothelial growth factor therapy","volume":"32","author":"Valikodath","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"2023110816291126700_B57","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/IAE.0000000000003196","article-title":"Factors assoicated with reactivation after intravitreal ranibizumab therapy in infants with retinopathy of prematurity","volume":"41","author":"Iwahashi","year":"2021","journal-title":"Retina"},{"issue":"8","key":"2023110816291126700_B58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3928\/23258160-20180803-11","article-title":"Late ROP reactivation and retinal detachment in a teenager","volume":"49","author":"Golas","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"2023110816291126700_B59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3928\/23258160-20170301-10","article-title":"Reactivation of retinopathy of prematurity three years after treatment with bevacizumab","volume":"48","author":"Hajrasouliha","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2023110816291126700_B60","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.2147\/OPTH.S288043","article-title":"Oculocardiac reflex during ROP exams","volume":"14","author":"Schumacher","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"2023110816291126700_B61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000079542","article-title":"Screening for retinopathy of prematurity: is it painful?","volume":"86","author":"Belda","year":"2004","journal-title":"Biol Neonate"},{"issue":"3","key":"2023110816291126700_B62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1891\/0730-0832.29.3.143","article-title":"The retinopathy of prematurity screening examination: ensuring a safe and efficient examination while minimizing infant discomfort","volume":"29","author":"Hered","year":"2010","journal-title":"Neonatal Netw"},{"issue":"5","key":"2023110816291126700_B63","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jpeds.2015.07.050","article-title":"Safety of ROP examination and imaging in premature infants","volume":"167","author":"Wade","year":"2015","journal-title":"J Pediatr"},{"issue":"12","key":"2023110816291126700_B64","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaophthalmol.2018.4290","article-title":"Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal growth and retinopathy of prematurity (G-ROP) study","volume":"136","author":"Quinn","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"2023110816291126700_B65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/pch\/pxz085","article-title":"Refining evidence-based retinopathy of prematurity screening guidelines: the SCREENROP study","volume":"25","author":"Sabri","year":"2019","journal-title":"Paediatr Child Health"},{"issue":"12","key":"2023110816291126700_B66","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity","volume":"124","author":"L\u00f6fqvist","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2023110816291126700_B67","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstr\u00f6m","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"2023110816291126700_B68","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archophthalmol.2010.31","article-title":"Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity","volume":"128","author":"Wu","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2023110816291126700_B69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaophthalmol.2013.566","article-title":"Efficacy of the screening algorithm WINROP in a Korean population of preterm infants","volume":"131","author":"Choi","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"2023110816291126700_B70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0034-1376389","article-title":"Using WINROP as an adjuvant screening tool for retinopathy of prematurity in southern Taiwan","volume":"30","author":"Ko","year":"2015","journal-title":"Am J Perinatol"},{"issue":"9","key":"2023110816291126700_B71","doi-asserted-by":"crossref","first-page":"e73256","DOI":"10.1371\/journal.pone.0073256","article-title":"WINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infants","volume":"8","author":"Lundgren","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2023110816291126700_B72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000351297","article-title":"The use of the WINROP screening algorithm for the prediction of retinopathy of prematurity in a Chinese population","volume":"104","author":"Sun","year":"2013","journal-title":"Neonatology"},{"issue":"6","key":"2023110816291126700_B73","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archophthalmol.2012.215","article-title":"Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants","volume":"130","author":"Zepeda-Romero","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2023110816291126700_B74","doi-asserted-by":"crossref","first-page":"F29","DOI":"10.1136\/archdischild-2013-304101","article-title":"Prediction of severe retinopathy of prematurity using the WINROP algorithm in a birth cohort in south east Scotland","volume":"99","author":"Piyasena","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2023110816291126700_B75","article-title":"Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity [published online ahead of print May 12, 2021]","author":"Pivodic","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2023110816291126700_B76","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apa.14049","article-title":"Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity","volume":"107","author":"Lundgren","year":"2018","journal-title":"Acta Paediatr"},{"issue":"12","key":"2023110816291126700_B77","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archophthalmol.2012.2524","article-title":"The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model","volume":"130","author":"Binenbaum","year":"2012","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"1","key":"2023110816291126700_B78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaophthalmol.2019.4517","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria","volume":"138","author":"Binenbaum","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"2023110816291126700_B79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archopht.1994.01090140028007","article-title":"Laser therapy for retinopathy of prematurity","volume":"112","author":"Laser ROP Study Group","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"2023110816291126700_B80","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(01)01015-6","article-title":"A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. refractive outcome","volume":"109","author":"Connolly","year":"2002","journal-title":"Ophthalmology"},{"issue":"4","key":"2023110816291126700_B81","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ophtha.2012.01.003","article-title":"Current role of cryotherapy in retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"119","author":"Simpson","year":"2012","journal-title":"Ophthalmology"},{"issue":"9","key":"2023110816291126700_B82","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/bjo.2009.170704","article-title":"Treatment for retinopathy of prematurity in infants born before 27 weeks of gestation in Sweden","volume":"94","author":"Austeng","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2023110816291126700_B83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3928\/01913913-20131112-02","article-title":"Diode laser photocoagulation for retinopathy of prematurity: outcomes after 7 years of treatment","volume":"51","author":"Nicoara","year":"2014","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"2023110816291126700_B84","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archopht.123.5.621","article-title":"Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity","volume":"123","author":"Rezai","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"2023110816291126700_B85","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/eye.2012.302","article-title":"Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity","volume":"27","author":"Ells","year":"2013","journal-title":"Eye (Lond)"},{"issue":"11","key":"2023110816291126700_B86","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bjo.79.11.1012","article-title":"Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity","volume":"79","author":"O\u2019Keefe","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"2023110816291126700_B87","unstructured":"RCPCH\n          . Screening and treatment of retinopathy of prematurity - clinical guideline. Available at: https:\/\/www.rcpch.ac.uk\/resources\/screening-treatment- retinopathy-prematurity-clinical- guideline. Accessed May 24, 2021"},{"issue":"12","key":"2023110816291126700_B88","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/bjophthalmol-2015-307263","article-title":"Five years of treatment for retinopathy of prematurity in Sweden: results from SWEDROP, a national quality register","volume":"100","author":"Holmstr\u00f6m","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2023110816291126700_B89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-9071.2012.02839.x","article-title":"Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period","volume":"41","author":"Gunn","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"2023110816291126700_B90","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ophtha.2015.12.019","article-title":"Neonatal risk factors for treatment-Demanding retinopathy of prematurity: a Danish national study","volume":"123","author":"Slidsborg","year":"2016","journal-title":"Ophthalmology"},{"issue":"8","key":"2023110816291126700_B91","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/aos.12798","article-title":"Cost and effects of risk factor guided screening strategies for retinopathy of prematurity for different treatment strategies","volume":"93","author":"van den Akker-van Marle","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"2023110816291126700_B92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00055735-199306000-00013","article-title":"Laser treatment for retinopathy of prematurity","volume":"4","author":"McNamara","year":"1993","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"2023110816291126700_B93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1067\/mpa.2002.121452","article-title":"Clinical outcome of confluent laser photoablation for retinopathy of prematurity","volume":"6","author":"Fallaha","year":"2002","journal-title":"J AAPOS"},{"issue":"1","key":"2023110816291126700_B94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaapos.2004.10.007","article-title":"Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity","volume":"9","author":"Trigler","year":"2005","journal-title":"J AAPOS"},{"issue":"1","key":"2023110816291126700_B95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archopht.124.1.24","article-title":"Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP)","volume":"124","author":"Repka","year":"2006","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"10208","key":"2023110816291126700_B96","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"issue":"20","key":"2023110816291126700_B97","first-page":"4593","article-title":"Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders","volume":"57","author":"Presta","year":"1997","journal-title":"Cancer Res"},{"issue":"2","key":"2023110816291126700_B98","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2023110816291126700_B99","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/IAE.0000000000000535","article-title":"Plasma concentrations of vascular endothelial growth factor in retinopathy of prematurity after intravitreal bevacizumab injection","volume":"35","author":"Hong","year":"2015","journal-title":"Retina"},{"issue":"3","key":"2023110816291126700_B100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00417-017-3878-4","article-title":"Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity","volume":"256","author":"Huang","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"2023110816291126700_B101","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"issue":"1","key":"2023110816291126700_B102","doi-asserted-by":"crossref","first-page":"12695","DOI":"10.1038\/s41598-020-69684-7","article-title":"Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity","volume":"10","author":"Cheng","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"2023110816291126700_B103","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"2023110816291126700_B104","doi-asserted-by":"crossref","first-page":"806","DOI":"10.18240\/ijo.2020.05.17","article-title":"Laser therapy versus intravitreal injection of anti-VEGF agents in monotherapy of ROP: a meta-analysis","volume":"13","author":"Wang","year":"2020","journal-title":"Int J Ophthalmol"},{"issue":"10","key":"2023110816291126700_B105","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","article-title":"2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial","volume":"5","author":"Marlow","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"2023110816291126700_B106","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00417-018-4168-5","article-title":"Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity","volume":"257","author":"Sukgen","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"2023110816291126700_B107","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s10792-018-1040-x","article-title":"Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography","volume":"39","author":"Vural","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"3","key":"2023110816291126700_B108","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"12","key":"2023110816291126700_B109","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"2023110816291126700_B110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaophthalmol.2020.0334","article-title":"Short-term outcomes after very low-dose intravitreous bevacizumab for retinopathy of prematurity","volume":"138","author":"Wallace","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"2023110816291126700_B111","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamaophthalmol.2017.1055","article-title":"Assessment of lower doses of intravitreous bevacizumab for retinopathy of prematurity: a phase 1 dosing study","volume":"135","author":"Wallace","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"2023110816291126700_B112","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaophthalmol.2021.5864","article-title":"Low-dose bevacizumab-but what about long-term results?","volume":"140","author":"Harper","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"2023110816291126700_B113","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings","volume":"121","author":"Lepore","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"2023110816291126700_B114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/IAE.0000000000001126","article-title":"Retinal vascular development with 0.312 MG intravetreal bevacizumab to treat severe posterior retinotherapy of prematurity: a longitudinal fluorescein angiographic study","volume":"37","author":"Lorenz","year":"2017","journal-title":"Retina"},{"issue":"2","key":"2023110816291126700_B115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"2023110816291126700_B116","article-title":"Neurodevelopmental outcomes associated with intravitreal bevacizumab injections for retinopathy of prematurity [published online ahead of print April 21, 2021","author":"Webb","journal-title":"Adv Neonatal Care"},{"issue":"1","key":"2023110816291126700_B117","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/aos.14852","article-title":"Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study","volume":"100","author":"Stahl","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"2023110816291126700_B118","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","article-title":"Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study","volume":"126","author":"Fan","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"2023110816291126700_B119","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3928\/23258160-20200326-03","article-title":"Neurodevelopmental outcomes following intravitreal bevacizumab with laser versus laser photocoagulation alone for retinopathy of prematurity","volume":"51","author":"Ahmed","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"2023110816291126700_B120","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"2023110816291126700_B121","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41372-020-00884-9","article-title":"Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis","volume":"41","author":"Kaushal","year":"2021","journal-title":"J Perinatol"},{"issue":"6","key":"2023110816291126700_B122","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis","volume":"128","author":"Tsai","year":"2021","journal-title":"Ophthalmology"},{"issue":"1","key":"2023110816291126700_B123","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/eye.2017.150","article-title":"An international comparison of retinopathy of prematurity grading performance within the benefits of oxygen saturation targeting II trials","volume":"32","author":"Fleck","year":"2018","journal-title":"Eye (Lond)"},{"issue":"2","key":"2023110816291126700_B124","doi-asserted-by":"crossref","first-page":"e20183537","DOI":"10.1542\/peds.2018-3537","article-title":"Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment","volume":"144","author":"Natarajan","year":"2019","journal-title":"Pediatrics"},{"key":"2023110816291126700_B125","unstructured":"Novartis Pharmaceuticals\n          . RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of ranibizumab compared with laser therapy for the treatment of infants born prematurely with retinopathy of prematurity. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02640664. Accessed January 12, 2022"},{"issue":"5","key":"2023110816291126700_B126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.siny.2015.05.002","article-title":"Role of tele-medicine in retinopathy of prematurity screening in rural outreach centers in India - a report of 20,214 imaging sessions in the KIDROP program","volume":"20","author":"Vinekar","year":"2015","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"2023110816291126700_B127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0301-4738.126178","article-title":"The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting","volume":"62","author":"Vinekar","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"2023110816291126700_B128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaophthalmol.2014.4913","article-title":"Need for telemedicine in retinopathy of prematurity in middle-income countries: e-ROP vs KIDROP","volume":"133","author":"Vinekar","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"2023110816291126700_B129","doi-asserted-by":"crossref","first-page":"F6","DOI":"10.1136\/archdischild-2015-308704","article-title":"Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatment","volume":"101","author":"Gilbert","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2023110816291126700_B130","unstructured":"Vinekar\n              A\n            , DograMR, JayadevC, MurthyS, RaoSV, ShettyB. Evaluation of a new, low-cost, portable, wide-field, digital, retinal camera, \u201cNeo\u201d for screening infants for retinopathy of prematurity \u2013 a prospective, multi-center, validation report in Asian Indian infants. Available at: https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2557805. Accessed May 24, 2021"},{"key":"2023110816291126700_B131","article-title":"Enhancing image characteristics of retinal images of aggressive posterior retinopathy of prematurity using a novel software, (RetiView) [published online ahead of print July 9, 2015]","author":"Jayadev","journal-title":"BioMed Res Int"},{"issue":"2","key":"2023110816291126700_B132","first-page":"178","article-title":"Imaging in retinopathy of prematurity","volume":"8","author":"Valikodath","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"2023110816291126700_B133","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaapos.2010.11.019","article-title":"Combining ROPtool measurements of vascular tortuosity and width to quantify plus disease in retinopathy of prematurity","volume":"15","author":"Cabrera","year":"2011","journal-title":"J AAPOS"},{"issue":"9","key":"2023110816291126700_B134","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1167\/iovs.07-1524","article-title":"Plus disease in retinopathy of prematurity: development of composite images by quantification of expert opinion","volume":"49","author":"Chiang","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023110816291126700_B135","first-page":"1902","article-title":"Development and evaluation of reference standards for image-based telemedicine diagnosis and clinical research studies in ophthalmology","volume":"2014","author":"Ryan","year":"2014","journal-title":"AMIA Annu Symp Proc AMIA Symp"},{"issue":"2","key":"2023110816291126700_B136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.9.2.10","article-title":"Plus disease in retinopathy of prematurity: convolutional neural network performance using a combined neural network and feature extraction approach","volume":"9","author":"Yildiz","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"2023110816291126700_B137","doi-asserted-by":"crossref","first-page":"e2020016618","DOI":"10.1542\/peds.2020-016618","article-title":"Applications of artificial intelligence for retinopathy of prematurity screening","volume":"147","author":"Campbell","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"2023110816291126700_B138","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/tmj.2019.0004","article-title":"Automated detection and classification of telemedical retinopathy of prematurity images","volume":"26","author":"Vijayalakshmi","year":"2020","journal-title":"Telemed J E Health"},{"issue":"3","key":"2023110816291126700_B139","doi-asserted-by":"crossref","first-page":"e2020034314","DOI":"10.1542\/peds.2020-034314","article-title":"Artificial intelligence for ROP screening and to assess quality of care: progress and challenges","volume":"147","author":"Gilbert","year":"2021","journal-title":"Pediatrics"},{"issue":"7","key":"2023110816291126700_B140","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archopht.1987.01060070042025","article-title":"An international classification of retinopathy of prematurity: II. The classification of retinal detachment","volume":"105","author":"Aaberg","year":"1987","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"2023110816291126700_B141","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An International Classification of Retinopathy of Prematurity","volume":"102","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"2023110816291126700_B142","first-page":"145","article-title":"Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007-2018 national health insurance claims data","volume":"11","author":"Hong","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"2023110816291126700_B143","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3928\/23258160-20170630-06","article-title":"The Epidemiology of Retinopathy of Prematurity in the United States","volume":"48","author":"Ludwig","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"13","key":"2023110816291126700_B144","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1167\/iovs.13-12297","article-title":"Screening for retinopathy of prematurity in China: a neonatal units-based prospective study","volume":"54","author":"Xu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2023110816291126700_B145","doi-asserted-by":"crossref","first-page":"5918736","DOI":"10.1155\/2016\/5918736","article-title":"A prospective study of the incidence of retinopathy of prematurity in China: Evaluation of different screening criteria","volume":"2016","author":"Li","year":"2016","journal-title":"J Ophthalmol"},{"issue":"3","key":"2023110816291126700_B146","doi-asserted-by":"crossref","first-page":"847","DOI":"10.18203\/2349-3291.ijcp20162263","article-title":"Screening based on incidence of severe retinopathy of prematurity in a tertiary care center in India: are Indian infants different?","volume":"3","author":"Balakrishnan","year":"2016","journal-title":"Int J Contemp Pediatr"},{"issue":"1","key":"2023110816291126700_B147","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12886-018-0732-3","article-title":"Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis","volume":"18","author":"Azami","year":"2018","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"2023110816291126700_B148","first-page":"71","article-title":"Recommendations for Retinopathy of Prematurity screening in at-risk populations","volume":"106","author":"Grupo de Trabajo Colaborativo Multic\u00e9ntrico para la Prevenci\u00f3n de la Ceguera en la Infancia por Retinopat\u00eda del Prematuro","year":"2008","journal-title":"Arch Argent Pediatr"},{"issue":"5","key":"2023110816291126700_B149","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1590\/S0004-27492007000500028","article-title":"Brazilian guidelines proposal for screening and treatment of retinopathy of prematurity (ROP)","volume":"70","author":"Zin","year":"2007","journal-title":"Arq Bras Oftalmol"},{"issue":"10","key":"2023110816291126700_B150","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/pch\/15.10.667","article-title":"Retinopathy of prematurity: Recommendations for screening","volume":"15","author":"Jefferies","year":"2010","journal-title":"Paediatr Child Health"},{"issue":"2","key":"2023110816291126700_B151","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1542\/peds.2008-3579","article-title":"Systematic review of digital imaging screening strategies for retinopathy of prematurity","volume":"123","author":"Fielder","year":"2009","journal-title":"Pediatrics"},{"key":"2023110816291126700_B152","first-page":"322","article-title":"A multi-country, cross-sectional observational study of retinopathy of prematurity in Latin America and the Caribbean","volume":"39","author":"Firestein","year":"2016","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"2023110816291126700_B153","first-page":"253","volume-title":"National Neonatology Foundation\u2019s evidence based clinical practice guidelines 2010. Retinopathy of prematurity (NNF India, Guidelines)","author":"Pevajer","year":"2010"},{"issue":"5","key":"2023110816291126700_B154","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/APO.0000000000000313","article-title":"Retinopathy of Prematurity: How to Prevent the Third Epidemics in Developing Countries","volume":"9","author":"Azad","year":"2020","journal-title":"Asia-Pac J Ophthalmol Phila Pa"},{"issue":"2","key":"2023110816291126700_B155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.eye.6701437","article-title":"Severe retinopathy of prematurity: longitudinal observation of disease and screening implications","volume":"19","author":"Ells","year":"2005","journal-title":"Eye"},{"key":"2023110816291126700_B156","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria: A retrospective Italian analysis [published online ahead of print April 22, 2021]","author":"Caruggi","journal-title":"Eur J Ophthalmol"},{"key":"2023110816291126700_B157","unstructured":"Ministry of Health Malaysia\n          . Clinical Practice Guidelines: Retinopathy of Prematurity. Available at: https:\/\/www.moh.gov.my\/moh\/attachments\/3917.pdf. Accessed January 13, 2022"},{"issue":"4","key":"2023110816291126700_B158","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5693\/djo.01.2019.08.002","article-title":"The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela","volume":"25","author":"Bowe","year":"2019","journal-title":"Digit J Ophthalmol"},{"issue":"11","key":"2023110816291126700_B159","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/archophthalmol.2012.2357","article-title":"Swedish national register for retinopathy of prematurity (SWEDROP) and the evaluation of screening in Sweden","volume":"130","author":"Holmstr\u00f6m","year":"2012","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"12","key":"2023110816291126700_B160","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1136\/bjophthalmol-2017-311789","article-title":"Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units","volume":"102","author":"Bas","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"2023110816291126700_B161","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/eye.2008.128","article-title":"UK retinopathy of prematurity guideline","volume":"23","author":"Wilkinson","year":"2009","journal-title":"Eye"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-053924\/1561362\/peds_2021053924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-053924\/1561362\/peds_2021053924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T11:33:12Z","timestamp":1699443192000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/150\/3\/e2021053924\/188757\/Retinopathy-of-Prematurity-A-Global-Perspective"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":161,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,11]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-053924","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"article-number":"e2021053924"}}